Primary pulmonary hypertension: insights into pathogenesis from epidemiology
- PMID: 9741567
- DOI: 10.1378/chest.114.3_supplement.184s
Primary pulmonary hypertension: insights into pathogenesis from epidemiology
Abstract
Primary pulmonary hypertension (PPH) is a rare disease that affects young people predominantly of female gender. Early epidemiologic studies have shown that the diagnosis is usually made 1 to 2 years after symptoms onset, and the mean survival is reduced to 2 to 3 years thereafter. New insights into the pathogenesis of PPH by epidemiologic studies may be obtained through the utilization of informatic technologies coupled to a clear definition of the disease. Early stages of precapillary pulmonary hypertension could be identified through screening tests like echocardiography in populations with higher incidence, such as familial PPH and the conditions associated with pulmonary hypertension. These latter conditions are hemodynamically and pathologically similar to the primary form, and they can give insight into several possible aspects of the pathogenesis of PPH. Prospective registries are very useful in coordinating the collection of epidemiologic data, and new technologies, such as informatics, may improve the management and the continuous updating of the databases.
Similar articles
-
Primary pulmonary hypertension.Lancet. 2003 May 3;361(9368):1533-44. doi: 10.1016/S0140-6736(03)13167-4. Lancet. 2003. PMID: 12737878 Review.
-
Pulmonary arterial hypertension: epidemiology and registries.J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D51-9. doi: 10.1016/j.jacc.2013.10.023. J Am Coll Cardiol. 2013. PMID: 24355642 Review.
-
Pulmonary hypertension update.Compr Ther. 2000 Fall;26(3):190-6. doi: 10.1007/s12019-000-0008-7. Compr Ther. 2000. PMID: 10984824 Review.
-
Current management of primary pulmonary hypertension.BioDrugs. 2001;15(12):801-17. doi: 10.2165/00063030-200115120-00003. BioDrugs. 2001. PMID: 11784212 Review.
-
Primary pulmonary hypertension in Israel: a national survey.Chest. 2001 Jun;119(6):1801-6. doi: 10.1378/chest.119.6.1801. Chest. 2001. PMID: 11399707
Cited by
-
Eisenmenger syndrome and atrial septal defect: nature or nurture?Can J Cardiol. 2006 Nov;22(13):1133-6. doi: 10.1016/s0828-282x(06)70950-3. Can J Cardiol. 2006. PMID: 17102831 Free PMC article.
-
Increased right ventricular Septomarginal trabeculation mass is a novel marker for pulmonary hypertension: comparison with ventricular mass index and right ventricular mass.Invest Radiol. 2011 Sep;46(9):567-75. doi: 10.1097/RLI.0b013e31821b7041. Invest Radiol. 2011. PMID: 21577127 Free PMC article.
-
Integrated care and optimal management of pulmonary arterial hypertension.J Multidiscip Healthc. 2009 May 12;2:67-78. doi: 10.2147/jmdh.s3085. J Multidiscip Healthc. 2009. PMID: 21197349 Free PMC article.
-
Sildenafil in the treatment of pulmonary hypertension.Vasc Health Risk Manag. 2006;2(4):411-22. doi: 10.2147/vhrm.2006.2.4.411. Vasc Health Risk Manag. 2006. PMID: 17323595 Free PMC article. Review.
-
Pathogenic mechanisms of pulmonary arterial hypertension.J Mol Cell Cardiol. 2008 Jan;44(1):14-30. doi: 10.1016/j.yjmcc.2007.09.006. Epub 2007 Sep 20. J Mol Cell Cardiol. 2008. PMID: 17950310 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical